PRISM Mid-Day Movers: Consumer Products and BioTech are Today’s Leaders.
Shares of Sleep Number Corporation (Nasdaq: SNBR) are bouncing hard, up about 36%, as traders cover shorts and bottom‑fish a name that has been pricing in severe distress. The surge comes after the company beat Q4 2025 revenue expectations, outlined progress on its “Sleep Number Shifts” turnaround and more than $180 million in cost cuts, even as sales fell 16% last year and management has hired Guggenheim to review its heavily leveraged capital structure—leaving SNBR a high‑beta restructuring story where sentiment can swing quickly on any hint of fresh funding or improved liquidity.
Shares of Quince Therapeutics, Inc. (NASDAQ: QNCX) are trading higher, up about 24%, as speculative money leans into this deeply beaten‑down rare‑disease biotech following a series of balance‑sheet and strategic moves. The stock has been trading near cash value after its lead Phase 3 NEAT trial in ataxia‑telangiectasia failed earlier this year, but Quince has since slashed debt via a favorable settlement with the European Investment Bank and launched a formal strategic review with LifeSci Capital, turning QNCX into a high‑risk, event‑driven name where any update on a sale, merger, or asset deal can trigger outsized price swings.
Other Notable Movers:
New Horizon Aircraft Ltd., (HOVR) up 20%
Fathom Realty (FTHM) up 18%
WeedMaps Technology (MAPS) down -46%
